Glenmede Trust CO Na Astrazeneca PLC Transaction History
Glenmede Trust CO Na
- $20.6 Billion
- Q3 2024
A detailed history of Glenmede Trust CO Na transactions in Astrazeneca PLC stock. As of the latest transaction made, Glenmede Trust CO Na holds 191,132 shares of AZN stock, worth $12.8 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
191,132
Previous 184,324
3.69%
Holding current value
$12.8 Million
Previous $14.4 Million
3.6%
% of portfolio
0.07%
Previous 0.07%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...